Immunotherapy with genetically engineered T-cells that express the chimeric antigen receptor (CAR) has raised hopes for the treatment of pediatric malignancies. Although CAR T-cell development is on a fast-moving pace and evolution, the context of exploring novel targetable antigens has been neglected. In this review study, we analyze the prominent hematologic antigens targeted by engineered T-...

Background:Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has over 6 million deaths worldwide. Comorbidities like obesity, asthma, and neurological disorders are risk factors for illness in pediatric patients. The direct impact of COVID-19 on child mortality is limited, with only 0.4% occurring children under 20.
 Objective: To ...

Objective To evaluate the threshold for platelet transfusion in children admitted to a pediatric intensive care unit (PICU). This is a retrospective chart review study, conducted at our tertiary level PICU and is related to critically ill pediatric patients who required platelet transfusion. Methods We retrieved the target patient population data from our blood bank database. The patients were ...

An 11-year-old girl with low-grade fever, night sweats, thrombocytopenia, and an 8-year history of progressive splenomegaly underwent an elective splenectomy. Pathologic diagnosis was multiple splenic hamartoma. The patient’s symptoms resolved after the splenectomy. Since first described by Rokitansky in 1861, ;140 cases of splenic hamartoma have been described in the literature. Most of the sp...

An 11-year-old girl with low-grade fever, night sweats, thrombocytopenia, and an 8-year history of progressive splenomegaly underwent an elective splenectomy. Pathologic diagnosis was multiple splenic hamartoma. The patient’s symptoms resolved after the splenectomy. Since first described by Rokitansky in 1861, ;140 cases of splenic hamartoma have been described in the literature. Most of the sp...

An 11-year-old girl with low-grade fever, night sweats, thrombocytopenia, and an 8-year history of progressive splenomegaly underwent an elective splenectomy. Pathologic diagnosis was multiple splenic hamartoma. The patient’s symptoms resolved after the splenectomy. Since first described by Rokitansky in 1861, ;140 cases of splenic hamartoma have been described in the literature. Most of the sp...

An 11-year-old girl with low-grade fever, night sweats, thrombocytopenia, and an 8-year history of progressive splenomegaly underwent an elective splenectomy. Pathologic diagnosis was multiple splenic hamartoma. The patient’s symptoms resolved after the splenectomy. Since first described by Rokitansky in 1861, ;140 cases of splenic hamartoma have been described in the literature. Most of the sp...